BCL2A1 is Expressed in Myelofibrosis Specimens and JAK2-mutated UKE-1 Cells, Yet Does Not Inhibit Synergistic Cell Killing by BCL-XL Inhibitor Navitoclax Plus JAK1/2 Inhibitors, Including Ruxolitinib.
Cancer Research（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要